NuVasive | NUVA - Betriebsaufwand



Betriebsaufwand Veränderung Datum
Abbott USD 9.31B 104M 2026-03
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Orthofix International USD 213.79M 12.36M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03